Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway

Overview of attention for article published in Frontiers in oncology, February 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,930 followers.

RT @FrontOncology: New research: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signali…

27 Mar 2020

Reply Repost Favourite

RT @FrontOncology: New research: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signali…

12 Mar 2020

Reply Repost Favourite

New research: Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway: A heterozygous point mutation of p53 gene at codon 280 from AGA to ACA (R280T) frequently occurs in… https://t.co/XA48tkrVyA

12 Mar 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.